Comparison of Bactiguard endotracheal tube to Taperguard endotracheal tube in decreasing ventilator associated pneumonia in critically ill patients admitted to intensive care unit

Abstract

The contribution of different endotracheal tube in the prevention of ventilator-associated pneumonia is unclear.Therefore, in this study, we aimed to compare the prevalence of pneumonia in patients admitted to the intensive care unit under mechanical ventilation with Bactiguard endotracheal tube and Taperguard endotracheal tube. Materials and Methods: This randomized clinical trial with the participation of 90 patients admitted to the intensive care unit who required mechanical ventilation for more than 72 hours after random allocation were divided into two groups; One group was intubated with Taperguard chip tube and one group was intubated with Bactiguard chip tube. The incidence of ventilator-associated pneumonia and mortality in the two groups were assessed by T-Student Test, Mann – Whitney U Test (as needed), Chi-Square and logistic regression. For p <0.05, it was considered as a statistically significant level. Results: The rate of ventilator-related pneumonia in patients intubated with EVAC endotracheal tube was positive in 9 patients (20%) and positive in patients intubated with Bactiguard endotracheal tube in 14 patients (31.1%), which was a significant difference from No statistically observed between the two groups (P = 0.227). The rate of ventilator-associated pneumonia mortality was positive in 4 patients (8.9%) in patients intubated with EVAC endotracheal tube and positive in 8 patients (17.8%) in intubated patients with Bactiguard endotracheal tube. There was no statistically significant difference between the two groups (P = 0.215)